Market Place
Sourcing Support
Eyevensys Recap Highlights from Investigator Meeting, Presentations at ARVO 2022
11 May 2022 //
BUSINESSWIRE
Eyevensys upgrades ocular device to advance gene therapy trials
27 Sep 2021 //
FIERCEBIOTECH
Eyevensys Raises $ 12 Million in Series B Plus Funding Round
05 Aug 2021 //
BUSINESSWIRE
Eyevensys Raises $12M in a Series B Plus Funding Round
04 Aug 2021 //
BUSINESSWIRE
Eyevensys Receives FDA Orphan Drug Designation for EYS611 for Treatment
05 Oct 2020 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.